Conference Day One
Wednesday February 26, 2025

8:00am Registration & Morning Coffee

8:50 am Chair’s Opening Remarks

Advancing Lab Scale Continuous Manufacturing Using Automation & Analytics to Maximize Quality

9:00 am Exploring Amgen’s Insight Towards Process Technology Progression & Lab Automation to Enhance Efficiency for Small Molecule

  • Dan Griffin Associate Director of Engineering, Amgen Inc.

Synopsis

  • Moving towards industry 4.0 and innovative process technology to improve continuous manufacturing efficiency
  • Understanding what is being actioned at early-stage process development to increase automation-aided continuous manufacturing
  • Exploring how to use a flow-based experimental system to change pump flow rates in incorporating automation and data management

9:30 am Assessing Development of a Multi-Column Continuous Chromatography Process for Antibody Drug Conjugates

Synopsis

  • Assessing the benefits of implementing continuous chromatography: evaluating the advantages of integrating continuous chromatography in ADC manufacturing
  • Using mechanistic modeling for continuous chromatography optimization: applying mechanistic modeling to improve the development process for continuous chromatography in order to enhance efficiency and maintain purity
  • Addressing scale-up considerations: discussing considerations for scaling up the continuous chromatography process and the advantages of using scale-down models

10:00am Speed Networking & Refreshments

Shifting From Batch to Continuous Along the Production Line to Improve Flexibility & Manufacturing Efficiency

10:45 am Enhancing a Continuous Manufacturing process by Implementation of an Automatic Refill System

Synopsis

  • Eliminating process pauses by installation of an automatic refill system has increased production capacity and process capability of a solid oral dosage form manufacturing process
  • Understanding and navigating post approval changes of an established continuous manufacturing control strategy
  • Reduction of material handling by expansion of capabilities and integration to an existing continuous direct compression system.

11:15 am Session Reserved for CONTINUUS Pharmaceuticals

11:45 am Advancing Continuous Manufacturing in Cell & Gene Therapy for More Efficient Production

Synopsis

  • Implementing PAT tools, including non-invasive instruments and cutting-edge analytics to facilitate process monitoring
  • Contextualizing continuous processing for viral vector production to streamline cell and gene processes
  • Tapping into opportunities for continuous manufacturing to drive broader adoption of cell and gene therapies in clinical and commercial settings

12:15pm Networking Lunch

Perfecting Process Modeling & Streamlining Your Strategy for Quality Outcomes

1:15 pm Case Study: Streamlining Sanofi’s Process Modeling for Drug Substance Manufacturing for Scale-Up Success

Synopsis

  • Optimizing process modeling from development through to verification and scale up to minimize process errors
  • Outlining Sanofi’s digital development for drug substance process modeling to explore opportunities for process efficiency
  • Understanding current work being done to advance process modeling for drug substance

1:45 pm Roundtable Discussion: Evaluating Continuous Manufacturing for Your Drug Development to Help “Make the Shift” & Further Your Production Line

  • Ying Xu Head of Analytical Science, Stealth Biotech

Synopsis

  • What are priority factors when assessing process compatibility with continuous approaches?
  • How do you approach a cost-benefit analysis to best consider ROI?
  • Is continuous manufacturing truly the right way to go?

2:30 pm Leveraging Process Modeling & Risk-Based Decision-Making for Direct Compression to Facilitate the Transition to Continuous Manufacturing

Synopsis

  • Utilizing process models to identify optimal process parameters for scale-up and minimizing tech transfer challenges
  • Evaluating formulations to support decision-making for direct compression
  • Integrating DS-DP process models and risk assessments to ensure direct compression strategies are robust and future-proofed for a smooth transition to continuous manufacturing when required

3:00pm Afternoon Break & Poster Session

Synopsis

Grab this opportunity to share your current work ahead of your process development and CMC peers to hear specialized feedback to make your processes greener, more cost-effective, and highly controlled. 

Optimizing PAT Applications & Branching Out Across the Pipeline for Effective Production

3:45 pm Leveraging End-to-End PAT Applications From Exploration to GMP Implementation to Shorten Timelines Moving Towards Real-Time Release

  • Muthu Meiyappan Head of Technology Development & Implementation, Takeda Pharmaceutical Co. Ltd.

Synopsis

  • Exploring platform potential and portfolio strength to understand potential for investment in soft sensors to ensure ROI
  • Obtaining conditional release during biologics continuous monitoring to help shorten timelines and move closer to RTR
  • Addressing challenges surrounding late-stage implementation of PAT to equip for regulatory readiness 

4:15 pm Exploring Next Generation Business Drivers for CM & The Role of Technology

Synopsis

  • Describing the emerging business needs and operational strategy for innovative companies regarding continuous manufacturing
  • Identifying how current technologies and utilization cases are evolving to meet these needs
  • Asking how can further developments in technology, regulatory landscape, and external capabilities continue to progress and drive CM as the go-to manufacturing platform

4:45 pm Chair’s Closing Remarks & End of Conference Day One